| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.678 | 55.565 | 79.295 | 50.829 | 28.006 | 80.659 |
| Total Income - EUR | - | - | - | - | 8.678 | 61.879 | 84.446 | 55.955 | 33.116 | 87.764 |
| Total Expenses - EUR | - | - | - | - | 2.207 | 17.715 | 31.709 | 28.314 | 18.248 | 22.423 |
| Gross Profit/Loss - EUR | - | - | - | - | 6.471 | 44.163 | 52.737 | 27.640 | 14.868 | 65.340 |
| Net Profit/Loss - EUR | - | - | - | - | 6.384 | 43.890 | 52.178 | 27.233 | 14.634 | 62.921 |
| Employees | - | - | - | - | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Scoliomedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 35.546 | 38.360 | 37.963 | 31.033 | 23.923 | 23.304 |
| Current Assets | - | - | - | - | 12.103 | 29.476 | 42.277 | 12.825 | 1.881 | 97.311 |
| Inventories | - | - | - | - | 7 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 7.046 | 14.471 | 30.323 | 9.605 | 0 | 56.130 |
| Cash | - | - | - | - | 5.050 | 15.005 | 11.955 | 3.220 | 1.881 | 41.181 |
| Shareholders Funds | - | - | - | - | 6.426 | 43.940 | 60.564 | 27.281 | 16.662 | 62.969 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 13.037 | 1.035 | 2.430 | 4.404 | 2.115 | 55.740 |
| Income in Advance | - | - | - | - | 28.185 | 22.862 | 17.245 | 12.173 | 7.026 | 1.906 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Scoliomedica S.r.l.